These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6384159

  • 1. Modification of chemotherapy by nitroimidazoles.
    Siemann DW.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1585-94. PubMed ID: 6384159
    [Abstract] [Full Text] [Related]

  • 2. [Intensification of cytostatic action by radiosensitizers--a review of the present status of chemosensitization].
    Moldenhauer H, Rose H, Saul G, Wolf G, Kehrberg G.
    Radiobiol Radiother (Berl); 1984 Sep; 25(2):289-95. PubMed ID: 6234615
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
    Hinchliffe M, McNally NJ.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW, Maddison K, Wolf K.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [Abstract] [Full Text] [Related]

  • 5. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
    Siemann DW, Hill SA.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
    [Abstract] [Full Text] [Related]

  • 6. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW, Morrissey S, Wolf K.
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [Abstract] [Full Text] [Related]

  • 7. Chemical modifiers of cancer treatment.
    Coleman CN, Bump EA, Kramer RA.
    J Clin Oncol; 1988 Apr; 6(4):709-33. PubMed ID: 3282035
    [Abstract] [Full Text] [Related]

  • 8. Clinical perspectives for the use of new hypoxic cell sensitizers.
    Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1491-7. PubMed ID: 6216229
    [No Abstract] [Full Text] [Related]

  • 9. Chemopotentiation in vivo: no loss of sensitization with fractionation.
    Hill SA, Siemann DW.
    Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
    [Abstract] [Full Text] [Related]

  • 10. Effect of thiol manipulation on chemopotentiation by nitroimidazoles.
    Siemann DW, Flaherty AA, Penney DP.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1341-5. PubMed ID: 2715088
    [Abstract] [Full Text] [Related]

  • 11. Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
    Wallen CA, Moore SK, Wheeler KT.
    Int J Radiat Oncol Biol Phys; 1992 May; 22(4):727-30. PubMed ID: 1531976
    [Abstract] [Full Text] [Related]

  • 12. Sensitizers and radiation dose fractionation: results and interpretations.
    Hill RP.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1049-54. PubMed ID: 2943705
    [Abstract] [Full Text] [Related]

  • 13. Sensitizers and protectors in radiotherapy.
    Brown JM.
    Cancer; 1985 May 01; 55(9 Suppl):2222-8. PubMed ID: 2983876
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.
    Siemann DW.
    Br J Cancer; 1990 Sep 01; 62(3):348-53. PubMed ID: 2206941
    [Abstract] [Full Text] [Related]

  • 15. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
    Siemann DW.
    Int J Radiat Oncol Biol Phys; 1989 Apr 01; 16(4):1115-8. PubMed ID: 2703392
    [Abstract] [Full Text] [Related]

  • 16. The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
    Hinchliffe M, McNally NJ, Stratford MR.
    Br J Cancer; 1983 Sep 01; 48(3):375-83. PubMed ID: 6615699
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of chemotherapy agents.
    McNally NJ.
    Int J Radiat Oncol Biol Phys; 1982 Sep 01; 8(3-4):593-8. PubMed ID: 7107378
    [Abstract] [Full Text] [Related]

  • 18. The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.
    Hill SA, Bauer KD, Keng PC, Siemann DW.
    Int J Radiat Oncol Biol Phys; 1984 Sep 01; 10(9):1619-22. PubMed ID: 6480450
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of CCNU activity by misonidazole in metastases.
    Siemann DW, Alliet KL.
    Clin Exp Metastasis; 1987 Sep 01; 5(1):57-63. PubMed ID: 3829497
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of the effect of cytotoxic drugs by radiosensitizers.
    Martin WM, McNally NJ, De Ronde J.
    Br J Cancer; 1981 Jun 01; 43(6):756-66. PubMed ID: 7248157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.